A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE
Status:
Recruiting
Trial end date:
2022-06-15
Target enrollment:
Participant gender:
Summary
This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate
HTX-011 compared with bupivacaine HCl in subjects undergoing different surgical procedures.
Each parallel cohort will enroll subjects undergoing a unique surgical procedure: total
shoulder arthroplasty (TSA) in Cohort 1 and abdominoplasty in Cohort 2.